ASCRS 2023: Risk factors for glaucoma after infantile cataract surgery

Article

In this recent study, Bharti Nihalani-Gangwani, MD, and Deborah VanderVeen, MD, reported that 29% developed glaucoma in a large infant cohort and the risk factors at the American Society of Cataract and Refractive Surgery annual meeting in San Diego.

Image Credit: © ND STOCK - stock.adobe.com

A total of 212 patients (319 eyes) were included in the analysis. The patient median age at the time of cataract surgery was 50 days (range, 11-325 days), and the median follow-up was 8.8 years (range, 1-26.3 years), the researchers reported. (Adobe Stock/ND STOCK)

The true incidence rate of the development of glaucoma after pediatric patients undergo cataract surgery is unknown, with the rates ranging from 8% to 59%.

In this recent study, Bharti Nihalani-Gangwani, MD, from the Department of Ophthalmology, Children’s Hospital, and Deborah VanderVeen, MD, from the Department of Ophthalmology, Harvard Medical School, Boston, reported that 29% developed glaucoma in a large infant cohort and the risk factors at the American Society of Cataract and Refractive Surgery annual meeting.

The investigators undertook a chart review of patients that spanned 30 years. The inclusion criterion included follow-up for at least 1 year. In this study,the definition of glaucoma was an intraocular pressure that exceeded 25 mmHg at 2 consecutive visits and changes in the optic nerve head.

Drs Nihalani-Gangwani and VanderVeen evaluated the patient age at the time of cataract surgery; the presence of a micro-cornea, defined as a corneal diameter below 9 mm); the cataract morphology, the time to the development of glaucoma after cataract surgery, and the type of treatment.

Chart review results

A total of 212 patients (319 eyes) were included in the analysis. The patient median age at the time of cataract surgery was 50 days (range, 11-325 days), and the median follow-up was 8.8 years (range, 1-26.3 years), the researchers reported.

They found that the incidence of glaucoma after surgery in this pediatric cohort was 29%.

In 82% of the eyes in which glaucoma developed postoperatively, the patient age at the time of surgery was younger than 3 months (p=0.001). Other relevant factors in the development of glaucoma included the presence of a micro-cornea (44%, p<0.0001), poor pupillary dilation (10%, p=0.004), persistent fetal vasculature (12%, p=0.8), and anterior-segment dysgenesis (3%, p=0.02), the authors reported.

They also found that in the 76% of patients in whom the glaucoma developed within a year after the cataract surgery, surgical intervention was required in contrast to the 13% in whom glaucoma developed more than 1 year after the cataract surgery (p=0.0002). In that latter group, medical treatment was effective for controlling the later-onset glaucoma in 87%.

The take-aways from this study were the 29% incidence of glaucoma after cataract surgery and the major risk factors that included the younger age at surgery and the presence of a micro-cornea and poor pupillary dilation.

The related findings were that patients with early-onset glaucoma were more than likely going to need surgery, but glaucoma that developed later responded to medical therapy in a high percentage of patients.

Recent Videos
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.